KAYE EDWARD M. MD (CEO) sold 9.2% of their position (12.57K shares) of STOKE THERAPEUTICS, INC. on the open market
Open‑market sale worth $402.5K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 8/19/2026ACC: 0001522780-26-000007
DirectorOfficer· CEO
Since Jun 2019
-12.57K
Net shares
Net seller
$402.5K
Total sold
2
Open market trades
0B · 2S
4
Total transactions
26.25K acquired · 38.82K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+26.25K
Price / share
—
Trade value
—
% of position
23.7%
8/14/2026
110.87K→137.12K
Common Stock
Direct
Shares
−11.93K
Price / share
$32.01
Trade value
$381.85K
% of position
8.7%
8/18/2026
137.12K→125.19K
Common Stock
Direct
Shares
−637.00
Price / share
$32.47
Trade value
$20.68K
% of position
0.5%
8/18/2026
125.19K→124.56K
Total
Net shares
+13.68K
Net value
-$402.53K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/14/2026 | M · Option Exercise | +26.25K | — | — | 23.7% | 110.87K | 137.12K |
| Common Stock Direct | 8/18/2026 | S · Sale | −11.93K | $32.01 | $381.85K | 8.7% | 137.12K | 125.19K |
| Common Stock Direct | 8/18/2026 | S · Sale | −637.00 | $32.47 | $20.68K | 0.5% | 125.19K | 124.56K |
| Total | +13.68K | -$402.53K | ||||||
Derivative Transactions1
Performance Stock Units
Direct
Converts to
Common Stock
26.25K shares
Shares
−26.25K
Strike price
Held after
0.00
Exercisable
—
8/14/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Performance Stock Units Direct | Common Stock26.25K shares | 8/14/2026 | M · Option Exercise | −26.25K | — | 0.00 |